Corporate ActionSep 15, 2026, 10:31 AM
AstraZeneca CFO Aradhana Sarin Acquires 73 Shares
AI Summary
AstraZeneca PLC announced that its Chief Financial Officer, Dr. Aradhana Sarin, acquired 73 ordinary shares on September 14, 2026. This acquisition occurred following the vesting of certain dividend equivalent awards that had accrued in relation to her 2021 AstraZeneca Performance Share Plan (AZPSP) award. The underlying award vested on August 17, 2026, but due to processing timelines, dividend equivalents for the first interim dividend of 2026 vested separately. Shares were withheld to cover tax obligations.
Key Highlights
- Dr. Aradhana Sarin, CFO of AstraZeneca, acquired 73 ordinary shares.
- The shares were acquired on September 14, 2026, following the vesting of dividend equivalent awards.
- These awards accrued in relation to her 2021 AstraZeneca Performance Share Plan (AZPSP) award.
- The fair market value of an Ordinary Share at vesting was £114.60.
- Shares were withheld to satisfy tax obligations arising on vesting.
Price Impact
More from AZN